文献速递消化道肿瘤与早癌

DDIT4 使损伤诱导的化生过程中仅健康细胞得以增殖

DDIT4 Licenses Only Healthy Cells to Proliferate During Injury-induced Metaplasia.
PubMed 文献 · Gastroenterology · 2020-09-19

研究利用 DDIT4 缺陷小鼠与人胃细胞探讨化生增加肿瘤发生风险的机制。DDIT4 在正常胃主细胞表达、化生时降低;Ddit4 缺失使化生主细胞 mTORC1 持续升高,DNA 损伤下仍增殖,并增加 5-FU 处理细胞的增殖与小鼠自发肿瘤形成。

要点

  • DDIT4 在人与小鼠正常胃主细胞表达,主细胞化生时表达降低。
  • Ddit4 缺失使化生主细胞 mTORC1 持续活化,DNA 损伤下仍有丝分裂。
  • DDIT4 低表达与胃癌患者生存期较长相关。

核心结论

  • 损伤诱导的化生性增殖中,mTORC1 再活化许可失败与携带 DNA 损伤的细胞增殖增加相关,并与小鼠和人类肿瘤形成及生长增加相关。

研究设计与样本

  • 研究使用 DDIT4 缺陷小鼠与人类细胞,并以人胃组织芯片行 DDIT4 免疫组化分析。
  • C57BL/6 小鼠接受腹腔注射高剂量他莫昔芬诱导 SPEM、雷帕霉素阻断 mTORC1,并在饮水中给予 MNU 诱导自发胃肿瘤。
  • 用 CRISPR/Cas9 生成 DDIT4-/- 与对照人胃细胞,在体外及有或无 5-FU 处理的异种移植瘤中分析生长。

主要发现

  • DDIT4 在小鼠和人类正常胃主细胞表达,主细胞化生时降低。
  • Paligenosis 中的 Ddit4-/- 主细胞维持组成性高 mTORC1,尽管存在 DNA 损伤,化生细胞有丝分裂仍增加。
  • DDIT4 表达较低与胃癌患者生存期较长相关。
  • 5-FU 处理的 DDIT4-/- 人胃上皮细胞在 DNA 损伤下进入有丝分裂的细胞显著增加,体外和异种移植瘤中增殖增加。
  • MNU 处理的 Ddit4-/- 小鼠经他莫昔芬多轮诱导 paligenosis 后自发肿瘤发生增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: In stomach, metaplasia can arise from differentiated chief cells that become mitotic via paligenosis, a stepwise program. In paligenosis, mitosis initiation requires reactivation of the cellular energy hub mTORC1 after initial mTORC1 suppression by DNA damage induced transcript 4 (DDIT4 aka REDD1). Here, we use DDIT4-deficient mice and human cells to study how metaplasia increases tumorigenesis risk. METHODS: A tissue microarray of human gastric tissue specimens was analyzed by immunohistochemistry for DDIT4. C57BL/6 mice were administered combinations of intraperitoneal injections of high-dose tamoxifen (TAM) to induce spasmolytic polypeptide-expressing metaplasia (SPEM) and rapamycin to block mTORC1 activity, and N-methyl-N-nitrosourea (MNU) in drinking water to induce spontaneous gastric tumors. Stomachs were analyzed for proliferation, DNA damage, and tumor formation. CRISPR/Cas9-generated DDIT4-/- and control human gastric cells were analyzed for growth in vitro and in xenografts with and without 5-fluorouracil (5-FU) treatment. RESULTS: DDIT4 was expressed in normal gastric chief cells in mice and humans and decreased as chief cells became metaplastic. Paligenotic Ddit4-/- chief cells maintained constitutively high mTORC1, causing increased mitosis of metaplastic cells despite DNA damage. Lower DDIT4 expression correlated with longer survival of patients with gastric cancer. 5-FU-treated DDIT4-/- human gastric epithelial cells had significantly increased cells entering mitosis despite DNA damage and increased proliferation in vitro and in xenografts. MNU-treated Ddit4-/- mice had increased spontaneous tumorigenesis after multiple rounds of paligenosis induced by TAM. CONCLUSIONS: During injury-induced metaplastic proliferation, failure of licensing mTORC1 reactivation correlates with increased proliferation of cells harboring DNA damage, as well as increased tumor formation and growth in mice and humans.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Miao ZF, Sun JX, Adkins-Threats M, et al. DDIT4 Licenses Only Healthy Cells to Proliferate During Injury-induced Metaplasia. Gastroenterology. 2020. PMID: 32956680. doi:10.1053/j.gastro.2020.09.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。